Indirect Comparison Finds Bimekizumab More Effective Than Guselkumab in Psoriatic Arthritis

Patients included in the analysis had psoriatic arthritis and had either not been treated with biologic disease-modifying antirheumatic drugs or had an inadequate response or an intolerance to tumor necrosis factor inhibitors.

Related Keywords

Clin Pharmacol ,American College Of Rheumatology ,American College ,Rev Clin ,